TCT-544 Bioresorbable Coronary Devices in Clinical Practice: Immediate and 30-day Results of the Prospective REPARA Registry

TCT-544 Bioresorbable Coronary Devices in Clinical Practice: Immediate and 30-day Results of the Prospective REPARA Registry

Methods REPARA is a multicenter, prospective registry, designed to evaluate the efficacy and safety of the bioresorbable coronary device Absorb (Abbott Vascular, Santa Clara, California) in daily clinical practice in more than 2400 patients undergoing elective coronary intervention in native coronar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B222-B222
Hauptverfasser: Hernandez, Felipe, Pérez de Prado, Armando, Salinas, Pablo, Piñon, Pablo, Bassaganyas, Joan, Bosco, Alfonso Torres, Avanzas, Pablo, Sanchis, Juan, Lozano, Iñigo, Lopez-Minguez, Jose R, Gaviria, Koldo, Masotti, Monica, Andraka, Leire, Alonso Briales, Juan H, Moreno, Raul, Berenguer, Alberto, Romero, Pedro Martinez
Format: Artikel
Sprache:eng
Schlagworte:
Angina pectoris
Cardiology
Cardiovascular
Clinical medicine
Heart attacks
Internal Medicine
Stents
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods REPARA is a multicenter, prospective registry, designed to evaluate the efficacy and safety of the bioresorbable coronary device Absorb (Abbott Vascular, Santa Clara, California) in daily clinical practice in more than 2400 patients undergoing elective coronary intervention in native coronary arteries in Spain and Portugal. In-hospital MACE were 1.6% (1.1% periprocedural MI, 0.3% acute stent thrombosis, 0.2% TLR and 0.2% cardiac deaths).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.561